-
While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%
Monday, March 31, 2025 - 1:25am | 713Read More...As uncertainties surrounding trade policies, fresh recession fears, and persistent inflation kept the markets on tenterhooks throughout the past week, a handful of small-caps defied the odds by posting significant gains. These stocks, all part of the Russell 2000 index, have market caps lower than...
-
Notable Insider Buys of the Past Week: Mylan, Sonabank, Steak 'n Shake, U-Haul And More
Sunday, December 20, 2020 - 8:19am | 979Read More...Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Some chief executive officers were among the insiders making notable purchases this past week. Insiders made return trips to the buy window to increase their stakes, and one took advantage of a...
-
Insider Buys Of The Week: AbbVie, Energen, NuStar And More
Sunday, July 1, 2018 - 5:14pm | 775Read More...Insider buying can be an encouraging signal for potential investors. An activist investor took the next step in acquiring his target. Also, a couple of regular buyers returned to the buy windows this week. Conventional wisdom says that insiders and 10-percent owners really only buy shares of a...
-
J.P. Morgan Maintains Overweight Rating on Lexicon Pharmaceuticals
Friday, May 13, 2011 - 8:06am | 132Read More...J.P. Morgan is maintaining its OW rating on Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX). “We are maintaining our OW rating on LXRX following today's R&D Day in NY, at which the company provided several incremental updates across its development pipeline,” J.P. Morgan writes. “All programs are...
